S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
NASDAQ:PETQ

PetIQ - PETQ Stock Forecast, Price & News

$11.44
+0.21 (+1.87%)
(As of 03/31/2023 05:16 PM ET)
Add
Compare
Today's Range
$11.14
$11.56
50-Day Range
$9.32
$12.58
52-Week Range
$6.66
$25.40
Volume
175,974 shs
Average Volume
311,887 shs
Market Capitalization
$334.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.75

PetIQ MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
90.1% Upside
$21.75 Price Target
Short Interest
Healthy
7.87% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.11mentions of PetIQ in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
131.82%
From $0.44 to $1.02 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Medical Sector

240th out of 1,009 stocks

Drugs, Proprietaries, & Sundries Industry

5th out of 6 stocks


PETQ stock logo

About PetIQ (NASDAQ:PETQ) Stock

PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. It operates through the Products and Services segments. The Products segment produces and distributes pet medication and health and wellness products to the retail channel. The Services segment represents all veterinary services, and related product sales provided by the firm directly to consumers. Its brands include Advecta, Betsy Farms, Delightibles, Tex Ranch, Mimis Market, and PetLock. The company was founded by McCord Christensen in 2010 and is headquartered in Eagle, ID.

Receive PETQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter.

PETQ Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
Should Value Investors Buy PetIQ (PETQ) Stock?
Should You Retain Your Holdings in PetIQ (PETQ)?
Are Investors Undervaluing PetIQ (PETQ) Right Now?
PETQ or BSX: Which Is the Better Value Stock Right Now?
PetIQ (PETQ) Q3 Earnings and Revenues Beat Estimates
PetIQ, Inc. Reports Third Quarter 2022 Financial Results
See More Headlines
Receive PETQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter.

PETQ Company Calendar

Last Earnings
2/28/2023
Today
3/31/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PETQ
Fax
N/A
Employees
1,888
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$21.75
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+93.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-48,210,000.00
Pretax Margin
-5.14%

Debt

Sales & Book Value

Annual Sales
$921.51 million
Cash Flow
$2.86 per share
Book Value
$7.25 per share

Miscellaneous

Free Float
27,033,000
Market Cap
$328.25 million
Optionable
Optionable
Beta
1.87

Key Executives

  • McCord ChristensenMcCord Christensen
    Chairman & Chief Executive Officer
  • Michael SmithMichael Smith
    President & Chief Operating Officer
  • Zvi Glasman
    Chief Financial & Accounting Officer
  • Lauren Olavessen
    Chief Medical Officer & Senior Vice President
  • Darrin Harris
    Chief Information Officer & Senior Vice President













PETQ Stock - Frequently Asked Questions

Should I buy or sell PetIQ stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PETQ shares.
View PETQ analyst ratings
or view top-rated stocks.

What is PetIQ's stock price forecast for 2023?

3 brokers have issued 12 month price objectives for PetIQ's shares. Their PETQ share price forecasts range from $16.00 to $30.00. On average, they anticipate the company's share price to reach $21.75 in the next year. This suggests a possible upside of 93.7% from the stock's current price.
View analysts price targets for PETQ
or view top-rated stocks among Wall Street analysts.

How have PETQ shares performed in 2023?

PetIQ's stock was trading at $9.22 at the start of the year. Since then, PETQ stock has increased by 21.8% and is now trading at $11.23.
View the best growth stocks for 2023 here
.

When is PetIQ's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our PETQ earnings forecast
.

How were PetIQ's earnings last quarter?

PetIQ, Inc. (NASDAQ:PETQ) posted its earnings results on Tuesday, February, 28th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.26) by $0.08. The firm earned $184.08 million during the quarter, compared to analysts' expectations of $191.80 million. PetIQ had a positive trailing twelve-month return on equity of 9.72% and a negative net margin of 5.23%.

What ETF holds PetIQ's stock ?

ProShares Pet Care ETF holds 59,441 shares of PETQ stock, representing 0.70% of its portfolio.

What guidance has PetIQ issued on next quarter's earnings?

PetIQ issued an update on its first quarter 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $270.00 million-$290.00 million, compared to the consensus revenue estimate of $273.58 million.

What is Cord Christensen's approval rating as PetIQ's CEO?

10 employees have rated PetIQ Chief Executive Officer Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among the company's employees.

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

When did PetIQ IPO?

(PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

What is PetIQ's stock symbol?

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

Who are PetIQ's major shareholders?

PetIQ's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Boston Partners (5.32%), Aristotle Capital Boston LLC (4.02%), Nepsis Inc. (3.03%), Fred Alger Management LLC (2.94%), Millennium Management LLC (2.65%) and Brandywine Global Investment Management LLC (2.47%). Insiders that own company stock include Allan Hall, John Newland, Mark L First, Mccord Christensen, Michael A Smith, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis, Will Santana and Zvi Glasman.
View institutional ownership trends
.

How do I buy shares of PetIQ?

Shares of PETQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetIQ's stock price today?

One share of PETQ stock can currently be purchased for approximately $11.23.

How much money does PetIQ make?

PetIQ (NASDAQ:PETQ) has a market capitalization of $328.25 million and generates $921.51 million in revenue each year. The company earns $-48,210,000.00 in net income (profit) each year or ($1.65) on an earnings per share basis.

How many employees does PetIQ have?

The company employs 1,888 workers across the globe.

How can I contact PetIQ?

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The official website for the company is www.petiq.com. The company can be reached via phone at (208) 939-8900 or via email at jeff.sonnek@icrinc.com.

This page (NASDAQ:PETQ) was last updated on 3/31/2023 by MarketBeat.com Staff